Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | LGALS3 | P17931 | 6/20 | 0.43 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.43 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.43 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.42 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.42 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.41 |
| ▸ | CD69 | Q07108 | 1/20 | 0.40 |
| ▸ | PYGB | P11216 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23380129 | 1.00 | MAPK1 (0.46) | MAPK1ALDH1A1THRBLGALS3LGALS8 | |
| SCHEMBL21122214 | 1.00 | MAPK1 (0.46) | MAPK1ALDH1A1THRBLGALS3LGALS8 | |
| SCHEMBL26651047 | 1.00 | MAPK1 (0.46) | MAPK1ALDH1A1THRBLGALS3LGALS8 | |
| SCHEMBL26651092 | 1.00 | MAPK1 (0.46) | MAPK1ALDH1A1THRBLGALS3LGALS8 | |
| SCHEMBL12754153 | 1.00 | MAPK1 (0.46) | MAPK1ALDH1A1THRBLGALS3LGALS8 | |
| SCHEMBL16311989 | 0.91 | LGALS3 (0.53) | MAPK1ALDH1A1THRBLGALS3LGALS8 | |
| SCHEMBL21180426 | 0.91 | LGALS3 (0.53) | MAPK1ALDH1A1THRBLGALS3LGALS8 | |
| SCHEMBL14865928 | 0.91 | LGALS3 (0.53) | MAPK1ALDH1A1THRBLGALS3LGALS8 | |
| SCHEMBL15583488 | 0.91 | LGALS3 (0.53) | MAPK1ALDH1A1THRBLGALS3LGALS8 | |
| SCHEMBL16213792 | 0.91 | LGALS3 (0.53) | MAPK1ALDH1A1THRBLGALS3LGALS8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11760991-B2 | Multi-functional oxygenating microparticle loaded cell aggregates | THE UNIVERSITY OF AKRON (US) | 2023-09-19 | — | — | US | disclosed |
| US-20210147825-A1 | MULTI-FUNCTIONAL OXYGENATING MICROPARTICLE LOADED CELL AGGREGATES | THE UNIVERSITY OF AKRON | 2021-05-20 | — | — | US | disclosed |
| US-10335490-B2 | Fluorinated polymerizable hydrogels for wound dressings and methods of making same | THE UNIVERSITY OF AKRON | 2019-07-02 | — | — | US | disclosed |
| US-8563702-B2 | Composite fibre of alginate and chitosan | THE UNIVERSITY OF BOLTON EDUCATION CORPORATION (GB) | 2013-10-22 | — | — | US | disclosed |
| US-7883615-B2 | Selectively electrodepositing chitosan in spatially localized regions by contacting a conductive support of a substrate with an aqueous solution of a insoluble chitosan to form the polysaccharide hydrogel; coupling with biological cells and biomaterials | UNIVERSITY OF MARYLAND, COLLEGE PARK (US) | 2011-02-08 | — | — | US | disclosed |
| US-20090169639-A1 | PARTICLES FOR INJECTION AND PROCESSES FOR FORMING THE SAME | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2009-07-02 | — | — | US | disclosed |
| US-20090169639-A1 | PARTICLES FOR INJECTION AND PROCESSES FOR FORMING THE SAME | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2009-07-02 | — | — | US | disclosed |
| US-20090099353-A1 | COMPOSITE FIBRE OF ALGINATE AND CHITOSAN | THE UNIVERSITY OF BOLTON EDUCATION CORPORATION (GB) | 2009-04-16 | — | — | US | disclosed |
| US-20090099353-A1 | COMPOSITE FIBRE OF ALGINATE AND CHITOSAN | THE UNIVERSITY OF BOLTON EDUCATION CORPORATION (GB) | 2009-04-16 | — | — | US | disclosed |
| US-20070068824-A1 | Controlled electrochemical deposition of polysaccharide films and hydrogels, and materials formed therefrom | UNIVERSITY OF MARYLAND COLLEGE PARK | 2007-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090169639-A1 | PARTICLES FOR INJECTION AND PROCESSES FOR FORMING THE SAME | CD44, CD47, ITGB5 | MAPK1 3534/4885ALDH1A1 1940/4885THRB 3741/4885 |
| US-20090099353-A1 | COMPOSITE FIBRE OF ALGINATE AND CHITOSAN | ALG1, CROCC, COL2A1 | MAPK1 3358/4885ALDH1A1 2146/4885THRB 4519/4885 |
| US-10335490-B2 | Fluorinated polymerizable hydrogels for wound dressings and methods of making same | FLNB, FLNA, QSOX1 | MAPK1 1164/4885ALDH1A1 2358/4885THRB 4586/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.